Company: HCTI
Filing Date: 2025-03-05
Form Type: PRE 14C
Source: 0001213900-25-020571
Chunk: 1

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-05
Form: PRE 14C
Chunk 1
---
 Statement is
to notify holders of our Common Stock and Series A Preferred Stock as of the Record Date (the “Stockholders”) that
the Company’s Board of Directors (the “Board”) and the holders of a majority of our outstanding voting capital
stock (the “Majority Stockholders”) approved of the following corporate actions (the “Corporate Actions”):

| ● | amendment                                                                                     
 of our certificate of incorporation, as amended (“Certificate of Incorporation”),             
 to effect a reverse stock split of our Common Stock at a reverse stock split ratio ranging    
 from 1:2 to 1:250 inclusive, as determined by our Board in its sole discretion (the “Approval 
 of Certificate of Incorporation Amendment for Split”); and                                    |

| ● | amendment                                                                                           
 of our Certificate of Incorporation to increase the total number of authorized shares (the          
 “Increase in Authorized Shares”) from one hundred ten million (110,000,000)                         
 shares to one billion ten million (1,010,000,000) shares, consisting of one billion (1,000,000,000) 
 shares of Common Stock and ten million (10,000,000) shares of preferred stock (the “Approval        
 of Certificate of Incorporation Amendment for Increase in Authorized Shares”);                      
 and                                                                                                 |

On the Record Date, the Majority Stockholders
approved the Corporate Actions by written consent in place of a stockholders’ meeting as permitted under the Delaware General Company
Law (the “DGCL”) and our Bylaws. Accordingly, your consent is not required and is not being solicited in connection
with the approval of the Corporate Actions. Our Board is not soliciting your proxy or consent in connection with the Corporate Actions.
You are urged to read this Information Statement carefully and in its entirety for a description of the Corporate Actions approved by
the Board and the Majority Stockholders. Stockholders who were not afforded an opportunity to consent or otherwise vote with respect
to the Corporate Actions taken have no right under the DGCL or our Bylaws to dissent or require a vote of all Stockholders.

Pursuant to Rule 14c-2 under the Exchange Act,
the Corporate Actions will not become effective before a date which is twenty (20) calendar days after a Definitive Information Statement
is first provided to stockholders as of the Record Date (the “Effective Date”). The Information Statement will be
provided to our stockholders of record as of the close of business on the Record Date upon filing the Definitive